An estimate of lifelong costs and QALYs in renal replacement therapy based on patients' life expectancy.
about
Gender in the allocation of organs in kidney transplants: meta-analysisBenefit of kidney transplantation beyond 70 years of ageReducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysisCost of peritoneal dialysis and haemodialysis across the world.Cost effectiveness of the type II Boston keratoprosthesisHealth state utility values in patients undergoing endoscopic sinus surgery.The potential economic value of a Staphylococcus aureus vaccine among hemodialysis patients.Assessing the value of a total joint replacement.The Cost and Utility of Renal Transplantation in Malaysia.Lifetime costs for peritoneal dialysis and hemodialysis in patients in Taiwan.Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation.Home-based versus center-based care in children with cerebral palsy: a cost-effectiveness analysis.A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policy.More donors or more delayed graft function? A cost-effectiveness analysis of DCD kidney transplantation.Organ cross talk and remote organ damage following acute kidney injury.Estimating Health-State Utility Values in Kidney Transplant Recipients and Waiting-List Patients Using the EQ-5D-5L.Predicting hospital costs for patients receiving renal replacement therapy to inform an economic evaluation.Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.Comparing SF-6D and EQ-5D utilities across groups differing in health status.Separating managerial inefficiency from influences of the operating environment: an application in dialysis.Cost-Effectiveness of Maintenance Hemodialysis in Japan.The potential for a generally applicable mapping model between QLQ-C30 and SF-6D in patients with different cancers: a comparison of regression-based methods.Comparing the sensitivity of EQ-5D, SF-6D and 15D utilities to the specific effect of diabetic complications.Cost-utility estimation of surgical treatment of pancreatic carcinoma aimed at cure.Cost-effectiveness of homograft heart valve replacement surgery: an introductory study.Is the Rise in the Prevalence of Renal Replacement Therapy at Older Ages the Price for Living Longer?Comparing Treatment Modalities for End-Stage Renal Disease: A Meta-Analysis.Managing End-Stage Renal Disease in Older Patients: A Single Centre Experience with Renal Transplantation in the Elderly
P2860
Q26783190-E6EFA10F-6405-4A9A-9720-F2711678D52BQ33797543-423FB321-87A3-4922-B322-5AF015F45879Q33882186-15EEA7E6-16B0-4A1E-9524-1845D16FE8F9Q34348767-D69EEB6B-E9FE-4827-A24C-056CEA75AF59Q35227244-51FA5E96-7F06-4F1D-863B-26E2DDD89616Q35596345-F93CAB3B-2CB0-40E3-BA78-9DC987AB775EQ36020705-6B88F621-FCAA-43CA-A25E-72566E9EF443Q36986528-C3D31346-32C7-436C-A60A-4847A03FC148Q37097707-D2BB6C54-25F8-43CB-9FE2-6A5075201B16Q37389816-8B4344F4-114D-4BA3-AC90-942F4DC61A1EQ37501815-6AE4A93A-B38A-4AA8-8F0D-A0A5597E2E44Q37655686-9FA562E3-EB1F-4B8B-B62C-4C5C0A6EE306Q37889260-24DC3987-B16F-476E-A264-F80B808EB0D7Q38076762-44712E61-01A0-4B85-BA7B-5867FE5C744BQ38223326-76D66A17-9B13-4C32-BE09-6D61D394924EQ38676864-CAAB02FC-F29F-40F6-8A76-00093CA36856Q39174412-CF68B60C-F2AB-43A7-8CD3-5C1F9031BFDDQ40323097-FAAAA164-6C42-406C-B817-56D959DCE306Q42604991-53091AF9-D012-4F28-BBAA-9A5E2C442B15Q42661890-6F2EB200-0055-4FC9-9929-ABBEAB9E2F0BQ47960872-1DC5003E-B975-4500-A476-13296A18454EQ48060040-B5210E6F-53A8-4BE9-A54D-BFDED9E95F00Q48737171-7F63F8CD-51CF-4093-937E-819F9378F32CQ48737245-E2A415C3-C9B1-4683-8334-4584D3A5FBC2Q48944177-41936D57-E45A-45E0-B998-5DA7BB0DFC1AQ55280723-2EB846CD-B8A7-4C07-A4C1-CA6749FC5E0AQ55340476-5F7F18CA-1FEE-47D2-8E07-7DEF06698AB4Q59049763-6DAB76F8-E1AC-4303-A884-05E08A11ABE3
P2860
An estimate of lifelong costs and QALYs in renal replacement therapy based on patients' life expectancy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
An estimate of lifelong costs ...... on patients' life expectancy.
@en
An estimate of lifelong costs ...... on patients' life expectancy.
@nl
type
label
An estimate of lifelong costs ...... on patients' life expectancy.
@en
An estimate of lifelong costs ...... on patients' life expectancy.
@nl
prefLabel
An estimate of lifelong costs ...... on patients' life expectancy.
@en
An estimate of lifelong costs ...... on patients' life expectancy.
@nl
P1433
P1476
An estimate of lifelong costs ...... on patients' life expectancy.
@en
P2093
Nick Kontodimopoulos
P356
10.1016/J.HEALTHPOL.2007.10.002
P577
2007-11-09T00:00:00Z